Researchers have identified a crucial biochemical mechanism that could allow Huntington’s disease to be studied before symptoms appear, offering hope for early intervention. The team found that disrupted dopamine regulation in specific neurons, related to TrkB neurotrophin receptor signaling, may trigger Huntington’s onset. By targeting an enzyme called GSTO2, researchers prevented motor symptoms in a mouse model, suggesting this protein's role in the disease's progression.
